Search result
PAMELA – Prevention and Management of Phantom Limb Pain
Organisation: Jena University Hospital, Hannover Medical School (Clinic for Trauma Surgery and Clinic for Rehabilitation Medicine) and Routine Health Care GmbH, Düsseldorf
Partner organisation in partner country: Ukrainian Association for the Study of Pain
Autophagy: Recycling, Repair, Defense - AURA
Institution: Universitätsklinikum Jena
Applicants: Prof. Dr. Christian Hübner, Prof. Dr. Regine Heller
The IMMUNsysteme – YOung versus AGed – „ImmunYoAge“
Institution: Mainz Research School of Translational Medicine, Universitätsmedizin Mainz der Johannes Gutenberg Universität
Applicant: Prof. Dr. Julia Weinmann-Menke
TALENT: Dysfunctional ion homeostasis – Superordinated analogies of different cell types and diseases
Institution: Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Regensburg
Applicants: Prof. Dr. Stefan Wagner (Spokesman), Prof. Frank Schweda
Entstehung von hämatologischen Neoplasien und kardiovaskulären Erkrankungen auf dem Boden der klonalen Hämatopoese: Gemeinsamkeiten und Besonderheiten
Institution: Charité – Universitätsmedizin Berlin, Klinik m.S. für Hämatologie, Onkologie und Tumorimmunologie, Campus Virchowklinikum
Applicant: Prof. Dr. Frederik Damm
Else Kröner Fresenius Center for Optogenetic Therapies approved
Else Kröner Fresenius Foundation supports new research center for optogenetic therapies with 37.4 million euros over ten years at the University Medical Center Göttingen (UMG). State of Lower Saxony is strongly supporting the establishment of the center and, together with the UMG, is holding out the prospect of up to 22.6 million euros in additional funding. The new research building with costs of 32.7 million euros will be included in the construction planning by the state of Lower Saxony. The aim of the center is to develop innovative treatment approaches for patients suffering from deafness, blindness, gastric paralysis or movement deficits. The center will be integrated into the UMG.
The soluble HLA immunopeptidome as active modulator and biomarker for T cell immunity in malignant disease
Institution: Department of Peptide-based Immunotherapy, University and University Hospital Tübingen
Applicant: Prof. Dr. Juliane Walz
Aktivierung repetitiver Genomsequenzen zur Steigerung der Immunogenität maligner Hirntumore
Institution: Universitätsklinikum Freiburg
Antragsteller: Dr. Roman Sankowski
February 2024: $$ Multiomic spatial landscape of innate immune cells at human central nervous system borders
Journal: Nature Medicine 2024
Authr: Dr. Roman Sankowski
Institution: Institut für Neuropathologie, Universitätsklinikum Freiburg
Publikationspreis 2024 (only available in German)
Die Else Kröner-Fresenius-Stiftung vergibt bis zu fünf Publikationspreise für herausragende Publikationen, die aus der Förderung der Stiftung hervorgegangen und im Jahr 2023 erschienen sind.